This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Centre Leon Berard, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 5,383 
1 out of 39 
1 out of 1,853 
Years Active: 2025
Title: Renaud Prudent: Innovator in Cancer Treatment
Introduction
Renaud Prudent is a notable inventor based in Renage, France. He has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of two patents, Prudent's work focuses on enhancing the efficacy of anti-cancer agents.
Latest Patents
Renaud Prudent's latest patents include "Carbazole derivatives sensitizing cells to anti-cancer agents." This invention involves a compound that features a complex formula designed to improve the effectiveness of cancer therapies. His second patent, "Mitochondrial activity inhibitors targeting tumoral metabolism," relates to compounds that aim to disrupt the metabolic processes of tumors, thereby aiding in cancer treatment.
Career Highlights
Throughout his career, Renaud Prudent has worked with esteemed organizations such as the Centre Léon Bérard and the Centre National de la Recherche Scientifique (CNRS). His experience in these institutions has allowed him to develop groundbreaking solutions in the fight against cancer.
Collaborations
Some of Renaud Prudent's notable coworkers include Patrick Dallemagne and Peggy Suzanne. Their collaborative efforts have contributed to the advancement of research in cancer therapies.
Conclusion
Renaud Prudent's innovative work in cancer treatment showcases his dedication to improving patient outcomes. His patents reflect a commitment to scientific advancement and the potential to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile